Earnings
KIN
9.22
-0.11%
-0.01
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
11.62M
46.76M
--
624.00K
--
--
0.00
--
207.00K
--
3.42M
--
62.62M
31.63M
--
1.50M
--
--
--
--
58.00K
33.19M
95.81M
--
145.00K
0.00
--
--
--
--
--
5.64M
--
--
--
--
6.90M
18.50M
--
--
--
2.93M
21.44M
28.33M
4000.00
312.32M
-244.85M
--
--
--
67.48M
67.48M
95.81M
FY 2019-12-31
15.99M
55.72M
--
923.00K
--
--
0.00
--
4.22M
--
2.50M
--
79.34M
32.78M
--
1.84M
--
--
--
--
64.00K
34.68M
114.02M
--
1.26M
0.00
--
--
--
--
--
8.97M
--
--
--
0.00
10.22M
19.27M
--
--
--
2.61M
21.88M
32.10M
4000.00
304.96M
-223.06M
--
--
--
81.92M
81.92M
114.02M
FY 2018-12-31
56.30M
17.63M
--
903.00K
--
--
0.00
--
3.57M
--
1.66M
--
80.07M
26.34M
--
0.00
--
--
--
--
70.00K
26.41M
106.48M
--
3.58M
0.00
--
--
--
--
--
11.58M
--
--
--
21.00K
15.18M
0.00
--
--
--
94.00K
94.00K
15.28M
3000.00
252.88M
-161.67M
--
--
--
91.21M
91.21M
106.48M
FY 2017-12-31
34.81M
46.21M
--
--
--
--
0.00
--
--
--
797.00K
--
81.82M
7.46M
--
1.50M
--
--
--
--
49.00K
9.01M
90.82M
--
1.44M
0.00
--
--
--
--
--
4.59M
--
--
--
--
6.03M
0.00
--
--
--
115.00K
115.00K
6.14M
3000.00
196.69M
-111.98M
--
--
--
84.68M
84.68M
90.82M
FY 2016-12-31
6.69M
50.07M
--
--
--
--
0.00
--
--
--
1.28M
--
58.04M
2.44M
--
1.05M
--
--
--
--
46.00K
3.54M
61.58M
--
410.00K
0.00
--
--
--
--
--
3.46M
--
--
--
--
3.87M
0.00
--
--
--
29.00K
29.00K
3.90M
2000.00
138.81M
-81.10M
--
--
--
57.68M
57.68M
61.58M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out KIN latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Kindred Bio recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.